| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $6.3M | +45.9% |
| SG&A Expense | $9.8M | +18.5% |
| Pre-tax Income | -$5.6M | +55.8% |
| Net Income | -$5.6M | +55.8% |
| EPS (Basic) | $0.81 | -67.7% |
| EPS (Diluted) | $0.81 | -67.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.5M | +9.5% |
| Current Assets | $38.6M | +8.7% |
| Total Assets | $38.6M | +8.7% |
| Current Liabilities | $1.3M | -34.2% |
| Total Liabilities | $3.2M | +60.1% |
| Stockholders' Equity | $32.7M | -2.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.2M | -28.7% |
| Capital Expenditures | $7K | +131.8% |
| Investing Cash Flow | -$7K | -131.8% |
| Financing Cash Flow | $14.5M | -61.0% |
| Free Cash Flow | -$11.2M | -28.7% |